Evidence map›Paper›PMID 36296222›Full record

ArticleMicroorganisms2022

Impact of COVID-19 Countermeasures on Pediatric Infections.

Naomi Sakon, Tomoko Takahashi, Toshiaki Yoshida, Tatsuya Shirai, Jun Komano

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Naomi SakonOsaka Institute of Public Health, Osaka 5370025, Japan.
Tomoko TakahashiIwate Prefectural Research Institute for Environmental Science and Public Health, Morioka 0200857, Japan.
Toshiaki YoshidaOsaka Institute of Public Health, Osaka 5370025, Japan.
Tatsuya ShiraiOsaka Institute of Public Health, Osaka 5370025, Japan.
Jun KomanoDepartment of Microbiology and Infection Control, Faculty of Fharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 5691041, Japan.
Osaka Prefectural Institute of Public Health · JPOsaka University of Pharmaceutical Sciences · JPResearch Institute for Environmental Sciences and Public Health of Iwate Prefecture · JP

Funding

JSPS KAKEN 18KK0270
6 · The paper itself

Abstract

(1) Background: General infection control measures have been implemented at the societal level against COVID-19 since the middle of 2020, namely, hand hygiene, universal masking, and social distancing. The suppressive effect of the social implementation of general infection control measures on pediatric infections has not been systematically assessed. (2) Methods: We addressed this issue based on publicly available data on 11 pediatric infections reported weekly by sentinel sites in Osaka and Iwate prefectures in Japan since 2010. We obtained the 5-year average for 2015-2019 and compared it to the weekly report for 2020-2021. (3) Results: The rate of 6 of the 11 pediatric infections decreased significantly during 2020-2021, regardless of the magnitude of the prevalence of COVID-19 in both areas. However, only RSV infection, one of the six infections, was endemic in 2021. Exanthem subitum was not as affected by COVID-19 countermeasures as other diseases. (4) Conclusions: The social implementation of infectious disease control measures was effective in controling certain infectious diseases in younger age groups, where compliance with the countermeasures should not be as high as that of adults.

Indexed as

COVID-19infection control measuresmild lockdownpediatric infectionssocial implementation

Identifiers

PMID36296222
PMCPMC9608675
OpenAlexW4303857076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.